Pioglitazone Hydrochloride Tablet
Product Images NDC 65862-512

8 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pioglitazone Hydrochloride (NDC 65862-512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)
A line graph showing the mean change from baseline in HbA1c over 26 weeks in a placebo-controlled, dose-ranging study for Pioglitazone Hydrochloride tablets. The x-axis represents weeks (0 to 26), and the y-axis represents mean change. Four lines depict placebo, 15 mg, 30 mg, and 45 mg dosages, with higher doses generally showing greater reductions in HbA1c over time.*
FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablet Bottle))

Package Label-principal Display Panel (15 mg (30 Tablet Bottle))
Label for Pioglitazone Tablets USP 15 mg by Aurobindo Pharma Limited, containing 30 tablets. Includes NDC 65862-512-30, storage instructions, and distributor information for Aurobindo Pharma USA, Inc. The label states Rx only and includes a note to dispense the accompanying Medication Guide to each patient.*
FDA Label Image

Package Label-principal Display Panel (15 mg Blister Carton (3 x 10 Unit-dose))

Package Label-principal Display Panel (15 mg Blister Carton (3 x 10 Unit-dose))
Pioglitazone Tablets, USP 15 mg carton packaging label showing unit-dose tablet format with a count of 30 (3 x 10). The label includes storage instructions, a barcode, and highlights that the product is Rx only. Manufactured by Aurobindo Pharma Limited, distributed by Aurobindo Pharma USA, Inc. The label specifies the drug's active ingredient strength as 15 mg and cautions about child resistance and proper dispensing.*
FDA Label Image

Package Label-principal Display Panel (30 mg (30 Tablet Bottle))

Package Label-principal Display Panel (30 mg (30 Tablet Bottle))
Label for Pioglitazone Tablets, USP 30 mg, a tablet dosage form distributed by Aurobindo Pharma USA, Inc. The label indicates 30 tablets per container, with storage instructions and usage cautions. It shows NDC number 65862-513-30 and includes a barcode and manufacturer details stating Made in India by Aurobindo Pharma Limited.*
FDA Label Image

Package Label-principal Display Panel (30 mg Blister Carton (3 x 10 Unit-dose))

Package Label-principal Display Panel (30 mg Blister Carton (3 x 10 Unit-dose))
Label for Pioglitazone Tablets, USP 30 mg in unit-dose packaging. The label indicates 30 tablets (3 x 10) with a unit-dose format. It includes storage instructions, dosage information, and a warning that the package is not child-resistant. The labeler is Aurobindo Pharma Limited with distribution by Aurobindo Pharma USA, Inc. The label features the product name and strength prominently and includes a barcode.*
FDA Label Image

Package Label-principal Display Panel (45 mg (30 Tablet Bottle))

Package Label-principal Display Panel (45 mg (30 Tablet Bottle))
Label for Pioglitazone Tablets, USP 45 mg by Aurobindo Pharma Limited. The label shows the drug's strength (45 mg), quantity (30 tablets), and states 'Rx only.' It includes usage storage instructions, distributor information (Aurobindo Pharma USA, Inc., East Windsor, NJ), and a barcode on the right side. The label is primarily white with blue and purple accents.*
FDA Label Image

Package Label-principal Display Panel (45 mg Blister Carton (3 x 10 Unit-dose))

Package Label-principal Display Panel (45 mg Blister Carton (3 x 10 Unit-dose))
Carton packaging for Pioglitazone Tablets USP 45 mg, a drug for further processing, containing 30 (3 x 10) unit-dose tablets. The label includes dosage information, storage instructions, and the labeler name Aurobindo Pharma Limited. The package features the NDC 65862-514-10 and displays the distributor as Aurobindo Pharma USA, Inc. Made in India.*
FDA Label Image

Chemical Structure (Pioglitazone Str)

Chemical Structure (Pioglitazone Str)
Chemical structure of Pioglitazone Hydrochloride showing the molecular components including aromatic rings, sulfur, nitrogen, oxygen atoms, and associated hydrocarbon chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.